Clinical and pathophysiological correlates of basilar artery measurements in Fabry Disease.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
12 Jul 2024
Historique:
received: 03 06 2024
accepted: 28 06 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 12 7 2024
Statut: aheadofprint

Résumé

Alterations of the Basilar Artery (BA) anatomy have been suggested as a possible Magnetic Resonance Angiography (MRA) feature of Fabry Disease (FD). Nonetheless, no information about their clinical or pathophysiological correlates is available, limiting our comprehension of the real impact of vessel remodeling in FD. Brain MRIs of 53 FD subjects (40.7±12.4 years, M/F=23/30) were collected in this single center study. Mean BA diameter and its Tortuosity Index (TI) were calculated on MRA. Possible correlations between these metrics and clinical, laboratory and advanced imaging variables of the posterior circulation were tested. In a subgroup of 20 subjects, a two-year clinical and imaging follow-up was available, with possible longitudinal changes of these metrics and their ability in predicting clinical scores that were also probed. No significant association was found between MRA metrics and any clinical, laboratory or advanced imaging variable (ρ values ranging from -0.006 to 0.32). At the follow-up examination, no changes were observed over time for mean BA diameter (p = 0.84) and TI (p = 0.70). Finally, baseline MRA variables failed to predict the clinical status of FD patients at follow-up (p=0.42 and 0.66, respectively). Alterations of BA in FD lack of any significant association with clinical, laboratory or advanced imaging findings collected in this study. Furthermore, this lack of correlation seems constant over time, suggesting their stability over time. Taken together, all these results suggest that the role of BA dolichoectasia in FD should be reconsidered. CNS = Central Nervous System; FASTEX = FAbry STabilization indEX; FD = Fabry Disease; Gb3 = Globotriaosylceramide; LysoGb3 = globotriaosylsphingosine; MSSI = Mainz Severity Score Index.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Alterations of the Basilar Artery (BA) anatomy have been suggested as a possible Magnetic Resonance Angiography (MRA) feature of Fabry Disease (FD). Nonetheless, no information about their clinical or pathophysiological correlates is available, limiting our comprehension of the real impact of vessel remodeling in FD.
MATERIALS AND METHODS METHODS
Brain MRIs of 53 FD subjects (40.7±12.4 years, M/F=23/30) were collected in this single center study. Mean BA diameter and its Tortuosity Index (TI) were calculated on MRA. Possible correlations between these metrics and clinical, laboratory and advanced imaging variables of the posterior circulation were tested. In a subgroup of 20 subjects, a two-year clinical and imaging follow-up was available, with possible longitudinal changes of these metrics and their ability in predicting clinical scores that were also probed.
RESULTS RESULTS
No significant association was found between MRA metrics and any clinical, laboratory or advanced imaging variable (ρ values ranging from -0.006 to 0.32). At the follow-up examination, no changes were observed over time for mean BA diameter (p = 0.84) and TI (p = 0.70). Finally, baseline MRA variables failed to predict the clinical status of FD patients at follow-up (p=0.42 and 0.66, respectively).
CONCLUSIONS CONCLUSIONS
Alterations of BA in FD lack of any significant association with clinical, laboratory or advanced imaging findings collected in this study. Furthermore, this lack of correlation seems constant over time, suggesting their stability over time. Taken together, all these results suggest that the role of BA dolichoectasia in FD should be reconsidered.
ABBREVIATIONS BACKGROUND
CNS = Central Nervous System; FASTEX = FAbry STabilization indEX; FD = Fabry Disease; Gb3 = Globotriaosylceramide; LysoGb3 = globotriaosylsphingosine; MSSI = Mainz Severity Score Index.

Identifiants

pubmed: 38997124
pii: ajnr.A8403
doi: 10.3174/ajnr.A8403
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by American Journal of Neuroradiology.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest related to the content of this article.

Auteurs

Alessandra Scaravilli (A)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Serena Capasso (S)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Lorenzo Ugga (L)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Ivana Capuano (I)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Teodolinda Di Risi (TD)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Giuseppe Pontillo (G)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Eleonora Riccio (E)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Mario Tranfa (M)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Antonio Pisani (A)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Arturo Brunetti (A)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Sirio Cocozza (S)

From the Department of Advanced Biomedical Sciences (A.S., S.C., L.U., G.P., M.T., A.B, S.C.) and Department of Public Health (I.C., E.R., A.P.), University of Naples "Federico II", Naples, Italy; CEINGE -Advanced Biotechnologies (T.D.R.), Naples, Italy.

Classifications MeSH